Skip to main content

The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria

Boehncke, W.-H., Ludwig, R.J., Zollner, T.M., Ochsendorf, F., Kaufmann, R., Gibbs, Bernhard F (2003) The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria. British Journal of Dermatology, 148 (3). pp. 604-606. ISSN 0007-0963. (doi:10.1046/j.1365-2133.2003.05209_12.x) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:4812)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL:
http://dx.doi.org/10.1046/j.1365-2133.2003.05209_1...
Item Type: Article
DOI/Identification number: 10.1046/j.1365-2133.2003.05209_12.x
Subjects: R Medicine
Q Science > QR Microbiology > QR180 Immunology
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Bernhard F. Gibbs
Date Deposited: 05 Sep 2008 12:40 UTC
Last Modified: 16 Nov 2021 09:43 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/4812 (The current URI for this page, for reference purposes)

University of Kent Author Information

Gibbs, Bernhard F.

Creator's ORCID:
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.